Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia
Journal of Medical Research and Reviews · 2024 · 1
DOI: 10.5455/jmrr.20231226053523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Research and Reviews, 2024. Verfasst von Muhammad Ishaq und 7 weiteren Autor:innen.
Abstract (Originalsprache)
BACKGROUND: Drug repurposing is an important approach to treat COVID-19 pandemic. Among various drugs that were felt efficacious we had to use the ones that were low cost, efficacious and readily available. Antibacterial drug teicoplanin has shown some promise in this regard. This study evaluates the therapeutic benefits of using teicoplanin in COVID-19 pneumonia patients. METHODS: In this case-control study, 39 patients of COVID-19 were included. The controls (n=19) had received azithromycin for seven days while the cases (n=20) received teicoplanin for ten days. The primary outcomes included the limitations on activity due to illness, need for hospitalization, need for supplemental oxygen therapy and/or ventilation by the 14th day of starting treatment. While the secondary outcomes included same parameters recorded on interim basis by the 7th day of starting treatment. RESULTS: A total of 39 patients, including 12 females and 27 males diagnosed with COVID-19 were included in this study, who had received antibacterial drugs azithromycin (n=19) or teicoplanin (n=20) as part of the treatment. The teicoplanin group had a consistently lower prevalence of fever on days 7, 10 and 15 (p
Zitieren
APA
Ishaq, M., Afsar, N., Riaz, S., Abbas, M., Mukarram, M., Ishaq, K., Ishaq, S., & Ali, M. (2024). Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. Journal of Medical Research and Reviews, 1. https://doi.org/10.5455/jmrr.20231226053523
Vancouver
Ishaq M, Afsar N, Riaz S, Abbas M, Mukarram M, Ishaq K, et al. Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia. Journal of Medical Research and Reviews. 2024:1. doi:10.5455/jmrr.20231226053523
BibTeX
@article{Ishaq2024,
author = {Ishaq, Muhammad and Afsar, Nasir and Riaz, Syeda and Abbas, Muslim and Mukarram, Muhammad and Ishaq, Khizra and Ishaq, Shifa and Ali, Muhammad},
title = {Teicoplanin use is associated with rapid clinical improvement in COVID-19 pneumonia},
journal = {Journal of Medical Research and Reviews},
year = {2024},
number = {0},
pages = {1},
doi = {10.5455/jmrr.20231226053523}
}
EUVIMED